Assisted Reproductive Technology Market by Type, Diagnosis, End User

Description

List of Tables

[194 Pages Report] The Assisted Reproductive Technology Market size was estimated at USD 25.12 billion in 2023 and expected to reach USD 29.52 billion in 2024, at a CAGR 17.57% to reach USD 78.04 billion by 2030.

Global Assisted Reproductive Technology Market

KEY MARKET STATISTICS
Base Year [2023]	USD 25.12 billion
Estimated Year [2024]	USD 29.52 billion
Forecast Year [2030]	USD 78.04 billion
CAGR (%)	17.57%

Assisted Reproductive Technology Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Assisted Reproductive Technology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Assisted Reproductive Technology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Assisted Reproductive Technology Market, highlighting leading vendors and their innovative profiles. These include Carl Zeiss AG, CCB Kitazato, LLC, CooperSurgical, Inc. Cooper Companies Inc., Cryolab Ltd., Esco Micro Pte. Ltd.Esco Lifesciences Group, Ferring B.V., FUJIFILM Irvine Scientific, Inc., Genea Limited, INVO Bioscience, Merck & Co., Inc., Nidacon International AB, Planer PLC by Hamilton Thorne, Inc., Rocket Medical plc by Roko AB, Thermo Fisher Scientific company, and Vitrolife AB.

Market Segmentation & Coverage

This research report categorizes the Assisted Reproductive Technology Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Artificial Insemination
- Donor Conception
- Gamete Intrafallopian Transfer
- In Vitro Fertilization
- Ovulation Induction
- Surrogacy
Diagnosis
- Genetic Testing
- Hormone Testing
- Hysterosalpingography
- Imaging Testing
- Ovarian Reserve Testing
- Ovulation Testing
End User
- Clinics
- Gynecology Centers
- Hospitals
- In Vitro Fertilisation Centers
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Assisted Reproductive Technology Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Assisted Reproductive Technology Market?

3. What are the technology trends and regulatory frameworks in the Assisted Reproductive Technology Market?

4. What is the market share of the leading vendors in the Assisted Reproductive Technology Market?

5. Which modes and strategic moves are suitable for entering the Assisted Reproductive Technology Market?

Product Code: MRR-436901065AA1

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Assisted Reproductive Technology Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing number of infertility cases due to stress, pollution, and obesity
  - 5.1.1.2. Rising healthcare expenditure across emerging nations
  - 5.1.1.3. Increasing prevalence of ovarian & endometrial cancer and PCOS issues
- 5.1.2. Restraints
  - 5.1.2.1. High cost required for the procedure and lower success rate
- 5.1.3. Opportunities
  - 5.1.3.1. Initiatives from government and public organizations to increase awareness
  - 5.1.3.2. Technological advancements to reduce the treatment complications
- 5.1.4. Challenges
  - 5.1.4.1. Dearth of advanced infrastructure in developing economies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Assisted Reproductive Technology Market, by Type

6.1. Introduction
6.2. Artificial Insemination
6.3. Donor Conception
6.4. Gamete Intrafallopian Transfer
6.5. In Vitro Fertilization
6.6. Ovulation Induction
6.7. Surrogacy

7. Assisted Reproductive Technology Market, by Diagnosis

7.1. Introduction
7.2. Genetic Testing
7.3. Hormone Testing
7.4. Hysterosalpingography
7.5. Imaging Testing
7.6. Ovarian Reserve Testing
7.7. Ovulation Testing

8. Assisted Reproductive Technology Market, by End User

8.1. Introduction
8.2. Clinics
8.3. Gynecology Centers
8.4. Hospitals
8.5. In Vitro Fertilisation Centers

9. Americas Assisted Reproductive Technology Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Assisted Reproductive Technology Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Assisted Reproductive Technology Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
- 13.1.1. Carl Zeiss AG
- 13.1.2. CCB Kitazato, LLC
- 13.1.3. CooperSurgical, Inc. Cooper Companies Inc.
- 13.1.4. Cryolab Ltd.
- 13.1.5. Esco Micro Pte. Ltd.Esco Lifesciences Group
- 13.1.6. Ferring B.V.
- 13.1.7. FUJIFILM Irvine Scientific, Inc.
- 13.1.8. Genea Limited
- 13.1.9. INVO Bioscience
- 13.1.10. Merck & Co., Inc.
- 13.1.11. Nidacon International AB
- 13.1.12. Planer PLC by Hamilton Thorne, Inc.
- 13.1.13. Rocket Medical plc by Roko AB
- 13.1.14. Thermo Fisher Scientific company
- 13.1.15. Vitrolife AB
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing